Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$705,717,584
-$78,893,090 QoQ
Shares Held
29,307,209
+4.9% QoQ
Ownership
0.514%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#23
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 95%
None 5%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $27,851,957,097 across 16 Drug Manufacturers - General names. PFE ranks #9 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
16,320,446 | $5,909,959,895 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
39,819,151 | $5,030,751,525 | |
| 3 | LLY |
ELI LILLY & Co
|
3,694,152 | $4,430,877,092 | |
| 4 | JNJ |
Johnson & Johnson
|
15,674,093 | $3,980,749,389 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,611,171 | $2,391,535,466 | |
| 6 | AZN |
Astrazeneca PLC
|
10,177,013 | $1,929,765,193 | |
| 7 | ABBV |
AbbVie Inc.
|
7,114,782 | $1,790,363,732 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,033,480 | $923,849,108 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $705,717,584 | 29,307,209 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $784,610,674 | 27,941,976 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $678,775,459 | 27,260,059 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $772,957,242 | 30,335,842 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $709,023,408 | 29,250,141 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $767,709,168 | 30,296,337 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $781,524,419 | 29,458,139 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $777,869,107 | 26,878,684 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $749,120,199 | 26,773,417 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $813,778,041 | 29,325,335 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $694,595,101 | 24,126,263 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $797,900,888 | 24,054,896 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $674,064,390 | 18,376,892 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $693,299,090 | 16,992,625 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $823,850,392 | 16,078,267 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $680,722,676 | 15,555,820 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $685,328,826 | 13,071,311 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $862,017,236 | 16,650,903 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,177,266,670 | 19,936,777 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $878,936,734 | 20,435,637 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $821,113,136 | 20,968,160 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $648,173,823 | 17,890,528 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $616,646,157 | 16,752,137 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $679,025,732 | 18,502,082 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $638,413,184 | 19,523,319 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $675,611,435 | 20,698,908 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||